Epi-Drugs in Heart Failure

Overview of attention for article published in Frontiers in Cardiovascular Medicine, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 14,294 followers.

RT @FrancescoPaneni: Exciting times ahead with epi-drugs for the prevention of #heartfailure. Read our last review: https://t.co/Tgmq8RQEEL…

RT @FrancescoPaneni: Exciting times ahead with epi-drugs for the prevention of #heartfailure. Read our last review: https://t.co/Tgmq8RQEEL…

RT @FrancescoPaneni: Exciting times ahead with epi-drugs for the prevention of #heartfailure. Read our last review: https://t.co/Tgmq8RQEEL…

RT @FrancescoPaneni: Exciting times ahead with epi-drugs for the prevention of #heartfailure. Read our last review: https://t.co/Tgmq8RQEEL…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.